FDA Brief

Company record

Grimann S.A. de C.V.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Grimann S.A. de C.V..

Warning letters

  1. Grimann S.A. de C.V.

    FDA warns Grimann over Derofen Miel drug listing with contradictory active ingredients, label image, and package size.

    Low